NGM Biopharmaceuticals, Inc.
USD1.54
-0.02 (-1.28%)
CEO
David J. Woodhouse
IPO Date
2019-04-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.56
Prev. Close
$1.56
Day Low
$1.54
Day High
$1.57
52W Low
$0.60
52W High
$4.69
Market Cap
$0.13B
Volume
2.21M
| -2.5 |
| 31 Dec 2021 | FY | 89.9% | -146.2% | -33.9% | -28.3% | 0.03 | 6.18 | -12.0 |
| 31 Dec 2020 | FY | -87.7% | -107.6% | -33.6% | -28.6% | 0.00 | 7.24 | -22.1 |
| 31 Dec 2019 | FY | -24.8% | -27.5% | -8.6% | -7.5% | 0.00 | 8.94 | -32.6 |
| 31 Dec 2018 | FY | 100.0% | -0.5% | -0.3% | -0.2% | 0.00 | 5.17 | -1937.9 |
| 31 Dec 2017 | FY | 100.0% | -18.4% | 11.7% | -5.7% | 0.00 | 4.76 | -55.7 |
| 31 Dec 2016 | FY | 100.0% | -8.1% | 6.0% | -2.5% | 0.00 | 6.23 | -113.9 |
| -0.8 |
| 30 Jun 2023 | Q2 | 21.4% | -2688.8% | -19.9% | -17.3% | 0.01 | 7.19 | -1.4 |
| 31 Mar 2023 | Q1 | 50.2% | -2007.1% | -20.4% | -17.4% | 0.02 | 6.40 | -1.9 |
| 31 Dec 2022 | Q4 | 93.9% | -190.2% | -13.3% | -11.2% | 0.02 | 6.04 | -3.0 |
| 30 Sept 2022 | Q3 | 86.2% | -584.2% | -16.2% | -13.8% | 0.02 | 6.50 | -5.7 |
| 30 Jun 2022 | Q2 | 83.1% | -554.3% | -15.7% | -13.6% | 0.03 | 7.50 | -5.5 |
| 31 Mar 2022 | Q1 | 100.0% | -154.3% | -10.4% | -9.0% | 0.03 | 7.58 | -9.2 |
| 31 Dec 2021 | Q4 | 100.0% | -129.9% | -8.1% | -6.8% | 0.03 | 6.18 | -12.6 |
| 30 Sept 2021 | Q3 | 100.0% | -155.4% | -8.2% | -6.9% | 0.00 | 6.86 | -14.1 |